Primary and Secondary Prevention of Dyslipidemia: Established The
15
冠心病患者血脂异常的正确处理 (附病例分正确处理)关于病例的检出(例1)门诊病历号:488366 就诊日期 03-03-03病史摘
9
Lipid Lowering Substudy Trial of the Antihypertensive and Lipid-L
3
要想杜绝胆结石的再次来临就要对胆结石的病因有所了解,这样可以根本上帮助患者远离胆结石的侵害以及困扰,形成胆结石的病因有很多,大多数
36
The Effect of Pravastatin on Coronary Events after Myocardial Inf
3
血脂与冠心病--来自中国循证医学的证据解放军总医院 叶平--血脂康调整血脂对冠心病二级预防的研究国家九五攻关课题编号:96-906
14
Rationale and Design of the Cardiac Hospitalization Atheroscleros
3
编辑同志:您好! 我在一个网站上看到一篇文章,说猪蹄的胆固醇含量是117mg/100g,而在另一网站上,却说猪蹄的胆固醇是6200
7
ATPIII:识别和治疗高危患者的新方法ATP III: New Approaches in Identifying and Tr
9
选择正确的降脂治疗方案Selecting Successful Lipid-Lowering Treatments James M
7
血脂治疗与临床指南JNC 7: Classification and Management of Blood Pressure f
7
血脂领域重大循证研究汇总Gould AL et al. Circulation. 1998;97:946-952.Clinical
8
糖尿病脂代谢紊乱ATP III: Management of Diabetic DyslipidemiaPrimary targe
6
胰岛素抵抗、糖尿病与冠心病Epidemiology of Insulin Resistance, Diabetes Mellitu
9
代谢综合征Update on the Metabolic Syndrome Steven Haffner, MDExpert Pa
3
新治疗目标:HDLHDL as a Therapeutic Target Daniel J. Rader, M.D.1001602
9
HDL代谢的生理学和病理学意义HDL and Coronary Heart DiseasePhysiology and Patho
9
HDL的临床试验HDL and Coronary Heart DiseaseAngiographic and Clinical E
5
HDL的药物治疗NCEP ATP-II Cutpoints for TG and HDL-CParametermg/dLNorma
28
HDL和LDL风险评估与治疗The Pyramid of Recent Trials Relative Size of the V
13